It provides patients with a less painful and invasive screening option. Read more at straitstimes.com. Read more at ...
OSLO, Norway, June 8, 2026 /PRNewswire/ -- Photocure ASA (OSE: PHO), the Bladder Cancer Company, and Artera, a leading precision medicine company, announce launch of a joint research initiative. The ...
Expanded federal law says these states and parts of others were downwind, but many don’t know they could be compensated ...
Consumer Reports found measurable arsenic in every rice sample tested, and more than 40% could raise cancer risk over time.
Consumer Reports’ latest food safety investigation found some rice products contain concerning levels of a harmful heavy ...
Rice can carry a risk: inorganic arsenic, a dangerous form of a heavy metal and known carcinogen.
It's important to share any health changes with your doctor.
Fast Five Quiz: Low-Risk Myelodysplastic Syndrome What do you know about low-risk myelodysplastic syndrome? Check your knowledge with this quick quiz. Medscape Reference, July 10, 2026 Fast Five Quiz: ...
The Canadian Press on MSN
Can a blood test tell patients if their cancer is coming back? Researchers are on it
TORONTO — Researchers at Princess Margaret Cancer Centre in Toronto are working on a large trial to determine if a blood test ...
Scientists are asking an unusual question: what if one type of prostate cancer should no longer be called cancer? A new ...
The FDA has approved two immunotherapy combination therapies for adults with muscle-invasive bladder cancer. Pembrolizumab ...
The Food and Drug Administration approved a combination treatment by Merck & Co., Pfizer, and Astellas Pharma for a hard-to-treat form of bladder cancer. The agency greenlit Merck's Keytruda and its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results